REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.

Hiromichi NakajimaDaisuke KotaniHideaki BandoTakeshi KatoEiji OkiEiji ShinozakiYu SunakawaKentaro YamazakiSatoshi YukiYoshiaki NakamuraTakeharu YamanakaTakayuki YoshinoTakashi OhtaHiroya TaniguchiYoshinori Kagawa

Published in: BMC cancer (2021)

The REMARRY study: UMIN, UMIN000036424 . Registered date: April 5, 2019. The PURSUIT trial: jRCT, jRCTs031190096 . Registered date: October 1, 2019.

Keyphrases

wild type
epidermal growth factor receptor
metastatic colorectal cancer
tyrosine kinase
advanced non small cell lung cancer
small cell lung cancer
clinical trial
study protocol
bone marrow
mesenchymal stem cells
fine needle aspiration